{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "setwd(\"/home/victor/OneDrive/Online Courses/MITx 15.071x The Analytics Edge\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "'data.frame':\t1860 obs. of  3 variables:\n",
      " $ title   : chr  \"Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).\" \"Cell mediated immune status in malignancy--pretherapy and post-therapy assessment.\" \"Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breas\"| __truncated__ \"Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for \"| __truncated__ ...\n",
      " $ abstract: chr  \"\" \"Twenty-eight cases of malignancies of different kinds were studied to assess T-cell activity and population bef\"| __truncated__ \"BACKGROUND: Among breast cancer patients, nonresponse to initial neoadjuvant chemotherapy is associated with un\"| __truncated__ \"BACKGROUND: Taxanes are among the most active drugs for the treatment of metastatic breast cancer, and, as a co\"| __truncated__ ...\n",
      " $ trial   : int  1 0 1 1 1 0 1 0 0 0 ...\n"
     ]
    }
   ],
   "source": [
    "trials = read.csv(\"Unit5_1/Unit5_1/clinical_trial.csv\", stringsAsFactors = FALSE)\n",
    "str(trials)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "3708"
      ],
      "text/latex": [
       "3708"
      ],
      "text/markdown": [
       "3708"
      ],
      "text/plain": [
       "[1] 3708"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "max(nchar(trials$abstract))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\n",
       "FALSE  TRUE \n",
       " 1748   112 "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "table(nchar(trials$abstract) == 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "'A decade of letrozole: FACE.'"
      ],
      "text/latex": [
       "'A decade of letrozole: FACE.'"
      ],
      "text/markdown": [
       "'A decade of letrozole: FACE.'"
      ],
      "text/plain": [
       "[1] \"A decade of letrozole: FACE.\""
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "trials$title[which.min(nchar(trials$title))]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Loading required package: NLP\n"
     ]
    }
   ],
   "source": [
    "library(tm)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "corpusTitle = Corpus(VectorSource(trials$title))\n",
    "corpusAbstract = Corpus(VectorSource(trials$abstract))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Warning message in tm_map.SimpleCorpus(corpusTitle, tolower):\n",
      "“transformation drops documents”Warning message in tm_map.SimpleCorpus(corpusAbstract, tolower):\n",
      "“transformation drops documents”"
     ]
    }
   ],
   "source": [
    "corpusTitle = tm_map(corpusTitle, tolower)\n",
    "corpusAbstract = tm_map(corpusAbstract, tolower)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Warning message in tm_map.SimpleCorpus(corpusTitle, removePunctuation):\n",
      "“transformation drops documents”Warning message in tm_map.SimpleCorpus(corpusAbstract, removePunctuation):\n",
      "“transformation drops documents”"
     ]
    }
   ],
   "source": [
    "corpusTitle = tm_map(corpusTitle, removePunctuation)\n",
    "corpusAbstract = tm_map(corpusAbstract, removePunctuation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Warning message in tm_map.SimpleCorpus(corpusTitle, removeWords, stopwords(\"english\")):\n",
      "“transformation drops documents”Warning message in tm_map.SimpleCorpus(corpusAbstract, removeWords, stopwords(\"english\")):\n",
      "“transformation drops documents”"
     ]
    }
   ],
   "source": [
    "corpusTitle = tm_map(corpusTitle, removeWords, stopwords(\"english\"))\n",
    "corpusAbstract = tm_map(corpusAbstract, removeWords, stopwords(\"english\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Warning message in tm_map.SimpleCorpus(corpusTitle, stemDocument):\n",
      "“transformation drops documents”Warning message in tm_map.SimpleCorpus(corpusAbstract, stemDocument):\n",
      "“transformation drops documents”"
     ]
    }
   ],
   "source": [
    "corpusTitle = tm_map(corpusTitle, stemDocument)\n",
    "corpusAbstract = tm_map(corpusAbstract, stemDocument)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "dtmTitle = DocumentTermMatrix(corpusTitle)\n",
    "dtmAbstract = DocumentTermMatrix(corpusAbstract)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "dtmTitle = removeSparseTerms(dtmTitle, 0.95)\n",
    "dtmAbstract = removeSparseTerms(dtmAbstract, 0.95)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "dtmTitle = as.data.frame(as.matrix(dtmTitle))\n",
    "colnames(dtmTitle) = make.names(colnames(dtmTitle))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "dtmAbstract = as.data.frame(as.matrix(dtmAbstract))\n",
    "colnames(dtmAbstract) = make.names(colnames(dtmAbstract))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "31"
      ],
      "text/latex": [
       "31"
      ],
      "text/markdown": [
       "31"
      ],
      "text/plain": [
       "[1] 31"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "length(dtmTitle)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "335"
      ],
      "text/latex": [
       "335"
      ],
      "text/markdown": [
       "335"
      ],
      "text/plain": [
       "[1] 335"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "length(dtmAbstract)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<dl class=dl-horizontal>\n",
       "\t<dt>regard</dt>\n",
       "\t\t<dd>105</dd>\n",
       "\t<dt>seven</dt>\n",
       "\t\t<dd>108</dd>\n",
       "\t<dt>larg</dt>\n",
       "\t\t<dd>108</dd>\n",
       "\t<dt>avail</dt>\n",
       "\t\t<dd>108</dd>\n",
       "\t<dt>progesteron</dt>\n",
       "\t\t<dd>114</dd>\n",
       "\t<dt>trend</dt>\n",
       "\t\t<dd>115</dd>\n",
       "\t<dt>caus</dt>\n",
       "\t\t<dd>115</dd>\n",
       "\t<dt>comparison</dt>\n",
       "\t\t<dd>116</dd>\n",
       "\t<dt>hematolog</dt>\n",
       "\t\t<dd>117</dd>\n",
       "\t<dt>shown</dt>\n",
       "\t\t<dd>117</dd>\n",
       "\t<dt>enter</dt>\n",
       "\t\t<dd>117</dd>\n",
       "\t<dt>characterist</dt>\n",
       "\t\t<dd>119</dd>\n",
       "\t<dt>regress</dt>\n",
       "\t\t<dd>120</dd>\n",
       "\t<dt>major</dt>\n",
       "\t\t<dd>122</dd>\n",
       "\t<dt>defin</dt>\n",
       "\t\t<dd>123</dd>\n",
       "\t<dt>analyz</dt>\n",
       "\t\t<dd>124</dd>\n",
       "\t<dt>base</dt>\n",
       "\t\t<dd>124</dd>\n",
       "\t<dt>eight</dt>\n",
       "\t\t<dd>124</dd>\n",
       "\t<dt>X005</dt>\n",
       "\t\t<dd>124</dd>\n",
       "\t<dt>select</dt>\n",
       "\t\t<dd>124</dd>\n",
       "\t<dt>inform</dt>\n",
       "\t\t<dd>124</dd>\n",
       "\t<dt>proport</dt>\n",
       "\t\t<dd>125</dd>\n",
       "\t<dt>prolong</dt>\n",
       "\t\t<dd>125</dd>\n",
       "\t<dt>type</dt>\n",
       "\t\t<dd>126</dd>\n",
       "\t<dt>multicent</dt>\n",
       "\t\t<dd>126</dd>\n",
       "\t<dt>general</dt>\n",
       "\t\t<dd>126</dd>\n",
       "\t<dt>limit</dt>\n",
       "\t\t<dd>127</dd>\n",
       "\t<dt>histolog</dt>\n",
       "\t\t<dd>127</dd>\n",
       "\t<dt>need</dt>\n",
       "\t\t<dd>128</dd>\n",
       "\t<dt>andor</dt>\n",
       "\t\t<dd>128</dd>\n",
       "\t<dt>possibl</dt>\n",
       "\t\t<dd>130</dd>\n",
       "\t<dt>consid</dt>\n",
       "\t\t<dd>131</dd>\n",
       "\t<dt>main</dt>\n",
       "\t\t<dd>131</dd>\n",
       "\t<dt>start</dt>\n",
       "\t\t<dd>131</dd>\n",
       "\t<dt>import</dt>\n",
       "\t\t<dd>138</dd>\n",
       "\t<dt>second</dt>\n",
       "\t\t<dd>138</dd>\n",
       "\t<dt>estim</dt>\n",
       "\t\t<dd>139</dd>\n",
       "\t<dt>prevent</dt>\n",
       "\t\t<dd>143</dd>\n",
       "\t<dt>particip</dt>\n",
       "\t\t<dd>144</dd>\n",
       "\t<dt>human</dt>\n",
       "\t\t<dd>144</dd>\n",
       "\t<dt>obtain</dt>\n",
       "\t\t<dd>147</dd>\n",
       "\t<dt>detect</dt>\n",
       "\t\t<dd>148</dd>\n",
       "\t<dt>identifi</dt>\n",
       "\t\t<dd>148</dd>\n",
       "\t<dt>singl</dt>\n",
       "\t\t<dd>149</dd>\n",
       "\t<dt>independ</dt>\n",
       "\t\t<dd>149</dd>\n",
       "\t<dt>distant</dt>\n",
       "\t\t<dd>149</dd>\n",
       "\t<dt>doubleblind</dt>\n",
       "\t\t<dd>149</dd>\n",
       "\t<dt>evid</dt>\n",
       "\t\t<dd>150</dd>\n",
       "\t<dt>receptorposit</dt>\n",
       "\t\t<dd>152</dd>\n",
       "\t<dt>term</dt>\n",
       "\t\t<dd>153</dd>\n",
       "\t<dt>frequent</dt>\n",
       "\t\t<dd>153</dd>\n",
       "\t<dt>multivari</dt>\n",
       "\t\t<dd>154</dd>\n",
       "\t<dt>stabl</dt>\n",
       "\t\t<dd>154</dd>\n",
       "\t<dt>due</dt>\n",
       "\t\t<dd>154</dd>\n",
       "\t<dt>provid</dt>\n",
       "\t\t<dd>155</dd>\n",
       "\t<dt>potenti</dt>\n",
       "\t\t<dd>156</dd>\n",
       "\t<dt>secondari</dt>\n",
       "\t\t<dd>158</dd>\n",
       "\t<dt>remain</dt>\n",
       "\t\t<dd>158</dd>\n",
       "\t<dt>profil</dt>\n",
       "\t\t<dd>158</dd>\n",
       "\t<dt>progressionfre</dt>\n",
       "\t\t<dd>158</dd>\n",
       "\t<dt>superior</dt>\n",
       "\t\t<dd>161</dd>\n",
       "\t<dt>popul</dt>\n",
       "\t\t<dd>162</dd>\n",
       "\t<dt>X001</dt>\n",
       "\t\t<dd>162</dd>\n",
       "\t<dt>appear</dt>\n",
       "\t\t<dd>164</dd>\n",
       "\t<dt>mastectomi</dt>\n",
       "\t\t<dd>165</dd>\n",
       "\t<dt>experienc</dt>\n",
       "\t\t<dd>167</dd>\n",
       "\t<dt>sequenti</dt>\n",
       "\t\t<dd>168</dd>\n",
       "\t<dt>requir</dt>\n",
       "\t\t<dd>168</dd>\n",
       "\t<dt>side</dt>\n",
       "\t\t<dd>168</dd>\n",
       "\t<dt>X500</dt>\n",
       "\t\t<dd>169</dd>\n",
       "\t<dt>period</dt>\n",
       "\t\t<dd>170</dd>\n",
       "\t<dt>aromatas</dt>\n",
       "\t\t<dd>171</dd>\n",
       "\t<dt>new</dt>\n",
       "\t\t<dd>171</dd>\n",
       "\t<dt>sampl</dt>\n",
       "\t\t<dd>172</dd>\n",
       "\t<dt>within</dt>\n",
       "\t\t<dd>172</dd>\n",
       "\t<dt>wherea</dt>\n",
       "\t\t<dd>173</dd>\n",
       "\t<dt>five</dt>\n",
       "\t\t<dd>173</dd>\n",
       "\t<dt>vomit</dt>\n",
       "\t\t<dd>174</dd>\n",
       "\t<dt>pretreat</dt>\n",
       "\t\t<dd>175</dd>\n",
       "\t<dt>least</dt>\n",
       "\t\t<dd>177</dd>\n",
       "\t<dt>size</dt>\n",
       "\t\t<dd>177</dd>\n",
       "\t<dt>find</dt>\n",
       "\t\t<dd>177</dd>\n",
       "\t<dt>postop</dt>\n",
       "\t\t<dd>177</dd>\n",
       "\t<dt>analys</dt>\n",
       "\t\t<dd>177</dd>\n",
       "\t<dt>conduct</dt>\n",
       "\t\t<dd>177</dd>\n",
       "\t<dt>life</dt>\n",
       "\t\t<dd>178</dd>\n",
       "\t<dt>confirm</dt>\n",
       "\t\t<dd>178</dd>\n",
       "\t<dt>involv</dt>\n",
       "\t\t<dd>180</dd>\n",
       "\t<dt>model</dt>\n",
       "\t\t<dd>180</dd>\n",
       "\t<dt>firstlin</dt>\n",
       "\t\t<dd>182</dd>\n",
       "\t<dt>inhibitor</dt>\n",
       "\t\t<dd>182</dd>\n",
       "\t<dt>accord</dt>\n",
       "\t\t<dd>182</dd>\n",
       "\t<dt>support</dt>\n",
       "\t\t<dd>183</dd>\n",
       "\t<dt>site</dt>\n",
       "\t\t<dd>183</dd>\n",
       "\t<dt>aim</dt>\n",
       "\t\t<dd>185</dd>\n",
       "\t<dt>better</dt>\n",
       "\t\t<dd>186</dd>\n",
       "\t<dt>function.</dt>\n",
       "\t\t<dd>188</dd>\n",
       "\t<dt>marker</dt>\n",
       "\t\t<dd>189</dd>\n",
       "\t<dt>qualiti</dt>\n",
       "\t\t<dd>189</dd>\n",
       "\t<dt>examin</dt>\n",
       "\t\t<dd>190</dd>\n",
       "\t<dt>can</dt>\n",
       "\t\t<dd>191</dd>\n",
       "\t<dt>common</dt>\n",
       "\t\t<dd>191</dd>\n",
       "\t<dt>although</dt>\n",
       "\t\t<dd>191</dd>\n",
       "\t<dt>set</dt>\n",
       "\t\t<dd>191</dd>\n",
       "\t<dt>subgroup</dt>\n",
       "\t\t<dd>192</dd>\n",
       "\t<dt>intraven</dt>\n",
       "\t\t<dd>192</dd>\n",
       "\t<dt>oper</dt>\n",
       "\t\t<dd>193</dd>\n",
       "\t<dt>longer</dt>\n",
       "\t\t<dd>193</dd>\n",
       "\t<dt>system</dt>\n",
       "\t\t<dd>193</dd>\n",
       "\t<dt>hundr</dt>\n",
       "\t\t<dd>195</dd>\n",
       "\t<dt>elig</dt>\n",
       "\t\t<dd>196</dd>\n",
       "\t<dt>low</dt>\n",
       "\t\t<dd>196</dd>\n",
       "\t<dt>tissu</dt>\n",
       "\t\t<dd>197</dd>\n",
       "\t<dt>nodeposit</dt>\n",
       "\t\t<dd>199</dd>\n",
       "\t<dt>seen</dt>\n",
       "\t\t<dd>199</dd>\n",
       "\t<dt>consist</dt>\n",
       "\t\t<dd>200</dd>\n",
       "\t<dt>respond</dt>\n",
       "\t\t<dd>200</dd>\n",
       "\t<dt>point</dt>\n",
       "\t\t<dd>202</dd>\n",
       "\t<dt>correl</dt>\n",
       "\t\t<dd>203</dd>\n",
       "\t<dt>anthracyclin</dt>\n",
       "\t\t<dd>207</dd>\n",
       "\t<dt>X5fluorouracil</dt>\n",
       "\t\t<dd>208</dd>\n",
       "\t<dt>growth</dt>\n",
       "\t\t<dd>208</dd>\n",
       "\t<dt>endpoint</dt>\n",
       "\t\t<dd>213</dd>\n",
       "\t<dt>death</dt>\n",
       "\t\t<dd>215</dd>\n",
       "\t<dt>fluorouracil</dt>\n",
       "\t\t<dd>215</dd>\n",
       "\t<dt>schedul</dt>\n",
       "\t\t<dd>215</dd>\n",
       "\t<dt>per</dt>\n",
       "\t\t<dd>218</dd>\n",
       "\t<dt>present</dt>\n",
       "\t\t<dd>218</dd>\n",
       "\t<dt>administr</dt>\n",
       "\t\t<dd>218</dd>\n",
       "\t<dt>design</dt>\n",
       "\t\t<dd>219</dd>\n",
       "\t<dt>enrol</dt>\n",
       "\t\t<dd>221</dd>\n",
       "\t<dt>end</dt>\n",
       "\t\t<dd>221</dd>\n",
       "\t<dt>X100</dt>\n",
       "\t\t<dd>225</dd>\n",
       "\t<dt>case</dt>\n",
       "\t\t<dd>233</dd>\n",
       "\t<dt>neutropenia</dt>\n",
       "\t\t<dd>234</dd>\n",
       "\t<dt>whether</dt>\n",
       "\t\t<dd>235</dd>\n",
       "\t<dt>lower</dt>\n",
       "\t\t<dd>236</dd>\n",
       "\t<dt>infus</dt>\n",
       "\t\t<dd>237</dd>\n",
       "\t<dt>found</dt>\n",
       "\t\t<dd>238</dd>\n",
       "\t<dt>nausea</dt>\n",
       "\t\t<dd>239</dd>\n",
       "\t<dt>prospect</dt>\n",
       "\t\t<dd>239</dd>\n",
       "\t<dt>agent</dt>\n",
       "\t\t<dd>240</dd>\n",
       "\t<dt>confid</dt>\n",
       "\t\t<dd>241</dd>\n",
       "\t<dt>prognost</dt>\n",
       "\t\t<dd>242</dd>\n",
       "\t<dt>radiotherapi</dt>\n",
       "\t\t<dd>244</dd>\n",
       "\t<dt>achiev</dt>\n",
       "\t\t<dd>245</dd>\n",
       "\t<dt>rang</dt>\n",
       "\t\t<dd>248</dd>\n",
       "\t<dt>lymph</dt>\n",
       "\t\t<dd>249</dd>\n",
       "\t<dt>X0001</dt>\n",
       "\t\t<dd>249</dd>\n",
       "\t<dt>carcinoma</dt>\n",
       "\t\t<dd>251</dd>\n",
       "\t<dt>demonstr</dt>\n",
       "\t\t<dd>251</dd>\n",
       "\t<dt>patholog</dt>\n",
       "\t\t<dd>254</dd>\n",
       "\t<dt>relaps</dt>\n",
       "\t\t<dd>254</dd>\n",
       "\t<dt>score</dt>\n",
       "\t\t<dd>254</dd>\n",
       "\t<dt>valu</dt>\n",
       "\t\t<dd>256</dd>\n",
       "\t<dt>advers</dt>\n",
       "\t\t<dd>256</dd>\n",
       "\t<dt>negat</dt>\n",
       "\t\t<dd>258</dd>\n",
       "\t<dt>develop</dt>\n",
       "\t\t<dd>259</dd>\n",
       "\t<dt>six</dt>\n",
       "\t\t<dd>261</dd>\n",
       "\t<dt>failur</dt>\n",
       "\t\t<dd>262</dd>\n",
       "\t<dt>randomis</dt>\n",
       "\t\t<dd>264</dd>\n",
       "\t<dt>safeti</dt>\n",
       "\t\t<dd>265</dd>\n",
       "\t<dt>methotrex</dt>\n",
       "\t\t<dd>265</dd>\n",
       "\t<dt>iii</dt>\n",
       "\t\t<dd>266</dd>\n",
       "\t<dt>endocrin</dt>\n",
       "\t\t<dd>266</dd>\n",
       "\t<dt>indic</dt>\n",
       "\t\t<dd>269</dd>\n",
       "\t<dt>suggest</dt>\n",
       "\t\t<dd>274</dd>\n",
       "\t<dt>initi</dt>\n",
       "\t\t<dd>275</dd>\n",
       "\t<dt>mbc</dt>\n",
       "\t\t<dd>276</dd>\n",
       "\t<dt>greater</dt>\n",
       "\t\t<dd>279</dd>\n",
       "\t<dt>continu</dt>\n",
       "\t\t<dd>281</dd>\n",
       "\t<dt>test</dt>\n",
       "\t\t<dd>282</dd>\n",
       "\t<dt>cours</dt>\n",
       "\t\t<dd>283</dd>\n",
       "\t<dt>stage</dt>\n",
       "\t\t<dd>286</dd>\n",
       "\t<dt>sever</dt>\n",
       "\t\t<dd>288</dd>\n",
       "\t<dt>axillari</dt>\n",
       "\t\t<dd>292</dd>\n",
       "\t<dt>neoadjuv</dt>\n",
       "\t\t<dd>293</dd>\n",
       "\t<dt>partial</dt>\n",
       "\t\t<dd>295</dd>\n",
       "\t<dt>investig</dt>\n",
       "\t\t<dd>295</dd>\n",
       "\t<dt>number</dt>\n",
       "\t\t<dd>296</dd>\n",
       "\t<dt>local</dt>\n",
       "\t\t<dd>300</dd>\n",
       "\t<dt>incid</dt>\n",
       "\t\t<dd>300</dd>\n",
       "\t<dt>reduct</dt>\n",
       "\t\t<dd>301</dd>\n",
       "\t<dt>hazard</dt>\n",
       "\t\t<dd>301</dd>\n",
       "\t<dt>premenopaus</dt>\n",
       "\t\t<dd>303</dd>\n",
       "\t<dt>prior</dt>\n",
       "\t\t<dd>305</dd>\n",
       "\t<dt>standard</dt>\n",
       "\t\t<dd>305</dd>\n",
       "\t<dt>without</dt>\n",
       "\t\t<dd>306</dd>\n",
       "\t<dt>dfs</dt>\n",
       "\t\t<dd>310</dd>\n",
       "\t<dt>mean</dt>\n",
       "\t\t<dd>310</dd>\n",
       "\t<dt>occur</dt>\n",
       "\t\t<dd>312</dd>\n",
       "\t<dt>her2</dt>\n",
       "\t\t<dd>314</dd>\n",
       "\t<dt>serum</dt>\n",
       "\t\t<dd>315</dd>\n",
       "\t<dt>tumour</dt>\n",
       "\t\t<dd>320</dd>\n",
       "\t<dt>administ</dt>\n",
       "\t\t<dd>322</dd>\n",
       "\t<dt>earli</dt>\n",
       "\t\t<dd>325</dd>\n",
       "\t<dt>well</dt>\n",
       "\t\t<dd>328</dd>\n",
       "\t<dt>drug</dt>\n",
       "\t\t<dd>332</dd>\n",
       "\t<dt>outcom</dt>\n",
       "\t\t<dd>335</dd>\n",
       "\t<dt>epirubicin</dt>\n",
       "\t\t<dd>339</dd>\n",
       "\t<dt>howev</dt>\n",
       "\t\t<dd>339</dd>\n",
       "\t<dt>baselin</dt>\n",
       "\t\t<dd>340</dd>\n",
       "\t<dt>perform</dt>\n",
       "\t\t<dd>342</dd>\n",
       "\t<dt>ratio</dt>\n",
       "\t\t<dd>344</dd>\n",
       "\t<dt>durat</dt>\n",
       "\t\t<dd>344</dd>\n",
       "\t<dt>interv</dt>\n",
       "\t\t<dd>349</dd>\n",
       "\t<dt>decreas</dt>\n",
       "\t\t<dd>350</dd>\n",
       "\t<dt>less</dt>\n",
       "\t\t<dd>351</dd>\n",
       "\t<dt>relat</dt>\n",
       "\t\t<dd>351</dd>\n",
       "\t<dt>determin</dt>\n",
       "\t\t<dd>352</dd>\n",
       "\t<dt>metastas</dt>\n",
       "\t\t<dd>352</dd>\n",
       "\t<dt>previous</dt>\n",
       "\t\t<dd>355</dd>\n",
       "\t<dt>express</dt>\n",
       "\t\t<dd>356</dd>\n",
       "\t<dt>report</dt>\n",
       "\t\t<dd>357</dd>\n",
       "\t<dt>cell</dt>\n",
       "\t\t<dd>359</dd>\n",
       "\t<dt>also</dt>\n",
       "\t\t<dd>364</dd>\n",
       "\t<dt>diseasefre</dt>\n",
       "\t\t<dd>364</dd>\n",
       "\t<dt>among</dt>\n",
       "\t\t<dd>365</dd>\n",
       "\t<dt>four</dt>\n",
       "\t\t<dd>369</dd>\n",
       "\t<dt>predict</dt>\n",
       "\t\t<dd>369</dd>\n",
       "\t<dt>toler</dt>\n",
       "\t\t<dd>373</dd>\n",
       "\t<dt>given</dt>\n",
       "\t\t<dd>374</dd>\n",
       "\t<dt>high</dt>\n",
       "\t\t<dd>378</dd>\n",
       "\t<dt>statist</dt>\n",
       "\t\t<dd>384</dd>\n",
       "\t<dt>background</dt>\n",
       "\t\t<dd>397</dd>\n",
       "\t<dt>paclitaxel</dt>\n",
       "\t\t<dd>397</dd>\n",
       "\t<dt>total</dt>\n",
       "\t\t<dd>397</dd>\n",
       "\t<dt>reduc</dt>\n",
       "\t\t<dd>400</dd>\n",
       "\t<dt>object</dt>\n",
       "\t\t<dd>400</dd>\n",
       "\t<dt>data</dt>\n",
       "\t\t<dd>405</dd>\n",
       "\t<dt>surgeri</dt>\n",
       "\t\t<dd>407</dd>\n",
       "\t<dt>event</dt>\n",
       "\t\t<dd>409</dd>\n",
       "\t<dt>measur</dt>\n",
       "\t\t<dd>411</dd>\n",
       "\t<dt>daili</dt>\n",
       "\t\t<dd>412</dd>\n",
       "\t<dt>may</dt>\n",
       "\t\t<dd>413</dd>\n",
       "\t<dt>higher</dt>\n",
       "\t\t<dd>415</dd>\n",
       "\t<dt>addit</dt>\n",
       "\t\t<dd>420</dd>\n",
       "\t<dt>estrogen</dt>\n",
       "\t\t<dd>421</dd>\n",
       "\t<dt>first</dt>\n",
       "\t\t<dd>421</dd>\n",
       "\t<dt>oral</dt>\n",
       "\t\t<dd>422</dd>\n",
       "\t<dt>hormon</dt>\n",
       "\t\t<dd>428</dd>\n",
       "\t<dt>age</dt>\n",
       "\t\t<dd>429</dd>\n",
       "\t<dt>chang</dt>\n",
       "\t\t<dd>431</dd>\n",
       "\t<dt>purpos</dt>\n",
       "\t\t<dd>434</dd>\n",
       "\t<dt>assign</dt>\n",
       "\t\t<dd>435</dd>\n",
       "\t<dt>similar</dt>\n",
       "\t\t<dd>438</dd>\n",
       "\t<dt>recurr</dt>\n",
       "\t\t<dd>465</dd>\n",
       "\t<dt>alon</dt>\n",
       "\t\t<dd>472</dd>\n",
       "\t<dt>placebo</dt>\n",
       "\t\t<dd>475</dd>\n",
       "\t<dt>node</dt>\n",
       "\t\t<dd>477</dd>\n",
       "\t<dt>phase</dt>\n",
       "\t\t<dd>481</dd>\n",
       "\t<dt>doxorubicin</dt>\n",
       "\t\t<dd>486</dd>\n",
       "\t<dt>everi</dt>\n",
       "\t\t<dd>487</dd>\n",
       "\t<dt>followup</dt>\n",
       "\t\t<dd>494</dd>\n",
       "\t<dt>activ</dt>\n",
       "\t\t<dd>509</dd>\n",
       "\t<dt>posit</dt>\n",
       "\t\t<dd>511</dd>\n",
       "\t<dt>docetaxel</dt>\n",
       "\t\t<dd>514</dd>\n",
       "\t<dt>bone</dt>\n",
       "\t\t<dd>514</dd>\n",
       "\t<dt>show</dt>\n",
       "\t\t<dd>516</dd>\n",
       "\t<dt>includ</dt>\n",
       "\t\t<dd>529</dd>\n",
       "\t<dt>either</dt>\n",
       "\t\t<dd>532</dd>\n",
       "\t<dt>status</dt>\n",
       "\t\t<dd>538</dd>\n",
       "\t<dt>benefit</dt>\n",
       "\t\t<dd>551</dd>\n",
       "\t<dt>factor</dt>\n",
       "\t\t<dd>552</dd>\n",
       "\t<dt>advanc</dt>\n",
       "\t\t<dd>556</dd>\n",
       "\t<dt>improv</dt>\n",
       "\t\t<dd>562</dd>\n",
       "\t<dt>three</dt>\n",
       "\t\t<dd>564</dd>\n",
       "\t<dt>one</dt>\n",
       "\t\t<dd>570</dd>\n",
       "\t<dt>versus</dt>\n",
       "\t\t<dd>570</dd>\n",
       "\t<dt>receptor</dt>\n",
       "\t\t<dd>573</dd>\n",
       "\t<dt>grade</dt>\n",
       "\t\t<dd>580</dd>\n",
       "\t<dt>cmf</dt>\n",
       "\t\t<dd>586</dd>\n",
       "\t<dt>analysi</dt>\n",
       "\t\t<dd>587</dd>\n",
       "\t<dt>postmenopaus</dt>\n",
       "\t\t<dd>590</dd>\n",
       "\t<dt>efficaci</dt>\n",
       "\t\t<dd>591</dd>\n",
       "\t<dt>associ</dt>\n",
       "\t\t<dd>604</dd>\n",
       "\t<dt>control</dt>\n",
       "\t\t<dd>621</dd>\n",
       "\t<dt>plus</dt>\n",
       "\t\t<dd>622</dd>\n",
       "\t<dt>progress</dt>\n",
       "\t\t<dd>622</dd>\n",
       "\t<dt>complet</dt>\n",
       "\t\t<dd>628</dd>\n",
       "\t<dt>cyclophosphamid</dt>\n",
       "\t\t<dd>632</dd>\n",
       "\t<dt>risk</dt>\n",
       "\t\t<dd>635</dd>\n",
       "\t<dt>assess</dt>\n",
       "\t\t<dd>668</dd>\n",
       "\t<dt>follow</dt>\n",
       "\t\t<dd>675</dd>\n",
       "\t<dt>observ</dt>\n",
       "\t\t<dd>700</dd>\n",
       "\t<dt>primari</dt>\n",
       "\t\t<dd>718</dd>\n",
       "\t<dt>increas</dt>\n",
       "\t\t<dd>729</dd>\n",
       "\t<dt>level</dt>\n",
       "\t\t<dd>743</dd>\n",
       "\t<dt>metastat</dt>\n",
       "\t\t<dd>755</dd>\n",
       "\t<dt>respect</dt>\n",
       "\t\t<dd>758</dd>\n",
       "\t<dt>regimen</dt>\n",
       "\t\t<dd>807</dd>\n",
       "\t<dt>conclus</dt>\n",
       "\t\t<dd>842</dd>\n",
       "\t<dt>time</dt>\n",
       "\t\t<dd>881</dd>\n",
       "\t<dt>two</dt>\n",
       "\t\t<dd>889</dd>\n",
       "\t<dt>method</dt>\n",
       "\t\t<dd>892</dd>\n",
       "\t<dt>treat</dt>\n",
       "\t\t<dd>893</dd>\n",
       "\t<dt>combin</dt>\n",
       "\t\t<dd>926</dd>\n",
       "\t<dt>evalu</dt>\n",
       "\t\t<dd>926</dd>\n",
       "\t<dt>clinic</dt>\n",
       "\t\t<dd>944</dd>\n",
       "\t<dt>diseas</dt>\n",
       "\t\t<dd>950</dd>\n",
       "\t<dt>cycl</dt>\n",
       "\t\t<dd>962</dd>\n",
       "\t<dt>overal</dt>\n",
       "\t\t<dd>962</dd>\n",
       "\t<dt>arm</dt>\n",
       "\t\t<dd>1038</dd>\n",
       "\t<dt>use</dt>\n",
       "\t\t<dd>1053</dd>\n",
       "\t<dt>toxic</dt>\n",
       "\t\t<dd>1065</dd>\n",
       "\t<dt>week</dt>\n",
       "\t\t<dd>1074</dd>\n",
       "\t<dt>mgm2</dt>\n",
       "\t\t<dd>1093</dd>\n",
       "\t<dt>tumor</dt>\n",
       "\t\t<dd>1122</dd>\n",
       "\t<dt>dose</dt>\n",
       "\t\t<dd>1123</dd>\n",
       "\t<dt>adjuv</dt>\n",
       "\t\t<dd>1162</dd>\n",
       "\t<dt>differ</dt>\n",
       "\t\t<dd>1176</dd>\n",
       "\t<dt>median</dt>\n",
       "\t\t<dd>1180</dd>\n",
       "\t<dt>day</dt>\n",
       "\t\t<dd>1245</dd>\n",
       "\t<dt>rate</dt>\n",
       "\t\t<dd>1253</dd>\n",
       "\t<dt>year</dt>\n",
       "\t\t<dd>1335</dd>\n",
       "\t<dt>effect</dt>\n",
       "\t\t<dd>1340</dd>\n",
       "\t<dt>compar</dt>\n",
       "\t\t<dd>1359</dd>\n",
       "\t<dt>trial</dt>\n",
       "\t\t<dd>1417</dd>\n",
       "\t<dt>women</dt>\n",
       "\t\t<dd>1484</dd>\n",
       "\t<dt>result</dt>\n",
       "\t\t<dd>1485</dd>\n",
       "\t<dt>random</dt>\n",
       "\t\t<dd>1520</dd>\n",
       "\t<dt>therapi</dt>\n",
       "\t\t<dd>1564</dd>\n",
       "\t<dt>month</dt>\n",
       "\t\t<dd>1575</dd>\n",
       "\t<dt>tamoxifen</dt>\n",
       "\t\t<dd>1632</dd>\n",
       "\t<dt>receiv</dt>\n",
       "\t\t<dd>1908</dd>\n",
       "\t<dt>surviv</dt>\n",
       "\t\t<dd>1927</dd>\n",
       "\t<dt>studi</dt>\n",
       "\t\t<dd>1965</dd>\n",
       "\t<dt>signific</dt>\n",
       "\t\t<dd>2043</dd>\n",
       "\t<dt>respons</dt>\n",
       "\t\t<dd>2051</dd>\n",
       "\t<dt>chemotherapi</dt>\n",
       "\t\t<dd>2344</dd>\n",
       "\t<dt>group</dt>\n",
       "\t\t<dd>2668</dd>\n",
       "\t<dt>treatment</dt>\n",
       "\t\t<dd>2894</dd>\n",
       "\t<dt>cancer</dt>\n",
       "\t\t<dd>3726</dd>\n",
       "\t<dt>breast</dt>\n",
       "\t\t<dd>3859</dd>\n",
       "\t<dt>patient</dt>\n",
       "\t\t<dd>8381</dd>\n",
       "</dl>\n"
      ],
      "text/latex": [
       "\\begin{description*}\n",
       "\\item[regard] 105\n",
       "\\item[seven] 108\n",
       "\\item[larg] 108\n",
       "\\item[avail] 108\n",
       "\\item[progesteron] 114\n",
       "\\item[trend] 115\n",
       "\\item[caus] 115\n",
       "\\item[comparison] 116\n",
       "\\item[hematolog] 117\n",
       "\\item[shown] 117\n",
       "\\item[enter] 117\n",
       "\\item[characterist] 119\n",
       "\\item[regress] 120\n",
       "\\item[major] 122\n",
       "\\item[defin] 123\n",
       "\\item[analyz] 124\n",
       "\\item[base] 124\n",
       "\\item[eight] 124\n",
       "\\item[X005] 124\n",
       "\\item[select] 124\n",
       "\\item[inform] 124\n",
       "\\item[proport] 125\n",
       "\\item[prolong] 125\n",
       "\\item[type] 126\n",
       "\\item[multicent] 126\n",
       "\\item[general] 126\n",
       "\\item[limit] 127\n",
       "\\item[histolog] 127\n",
       "\\item[need] 128\n",
       "\\item[andor] 128\n",
       "\\item[possibl] 130\n",
       "\\item[consid] 131\n",
       "\\item[main] 131\n",
       "\\item[start] 131\n",
       "\\item[import] 138\n",
       "\\item[second] 138\n",
       "\\item[estim] 139\n",
       "\\item[prevent] 143\n",
       "\\item[particip] 144\n",
       "\\item[human] 144\n",
       "\\item[obtain] 147\n",
       "\\item[detect] 148\n",
       "\\item[identifi] 148\n",
       "\\item[singl] 149\n",
       "\\item[independ] 149\n",
       "\\item[distant] 149\n",
       "\\item[doubleblind] 149\n",
       "\\item[evid] 150\n",
       "\\item[receptorposit] 152\n",
       "\\item[term] 153\n",
       "\\item[frequent] 153\n",
       "\\item[multivari] 154\n",
       "\\item[stabl] 154\n",
       "\\item[due] 154\n",
       "\\item[provid] 155\n",
       "\\item[potenti] 156\n",
       "\\item[secondari] 158\n",
       "\\item[remain] 158\n",
       "\\item[profil] 158\n",
       "\\item[progressionfre] 158\n",
       "\\item[superior] 161\n",
       "\\item[popul] 162\n",
       "\\item[X001] 162\n",
       "\\item[appear] 164\n",
       "\\item[mastectomi] 165\n",
       "\\item[experienc] 167\n",
       "\\item[sequenti] 168\n",
       "\\item[requir] 168\n",
       "\\item[side] 168\n",
       "\\item[X500] 169\n",
       "\\item[period] 170\n",
       "\\item[aromatas] 171\n",
       "\\item[new] 171\n",
       "\\item[sampl] 172\n",
       "\\item[within] 172\n",
       "\\item[wherea] 173\n",
       "\\item[five] 173\n",
       "\\item[vomit] 174\n",
       "\\item[pretreat] 175\n",
       "\\item[least] 177\n",
       "\\item[size] 177\n",
       "\\item[find] 177\n",
       "\\item[postop] 177\n",
       "\\item[analys] 177\n",
       "\\item[conduct] 177\n",
       "\\item[life] 178\n",
       "\\item[confirm] 178\n",
       "\\item[involv] 180\n",
       "\\item[model] 180\n",
       "\\item[firstlin] 182\n",
       "\\item[inhibitor] 182\n",
       "\\item[accord] 182\n",
       "\\item[support] 183\n",
       "\\item[site] 183\n",
       "\\item[aim] 185\n",
       "\\item[better] 186\n",
       "\\item[function.] 188\n",
       "\\item[marker] 189\n",
       "\\item[qualiti] 189\n",
       "\\item[examin] 190\n",
       "\\item[can] 191\n",
       "\\item[common] 191\n",
       "\\item[although] 191\n",
       "\\item[set] 191\n",
       "\\item[subgroup] 192\n",
       "\\item[intraven] 192\n",
       "\\item[oper] 193\n",
       "\\item[longer] 193\n",
       "\\item[system] 193\n",
       "\\item[hundr] 195\n",
       "\\item[elig] 196\n",
       "\\item[low] 196\n",
       "\\item[tissu] 197\n",
       "\\item[nodeposit] 199\n",
       "\\item[seen] 199\n",
       "\\item[consist] 200\n",
       "\\item[respond] 200\n",
       "\\item[point] 202\n",
       "\\item[correl] 203\n",
       "\\item[anthracyclin] 207\n",
       "\\item[X5fluorouracil] 208\n",
       "\\item[growth] 208\n",
       "\\item[endpoint] 213\n",
       "\\item[death] 215\n",
       "\\item[fluorouracil] 215\n",
       "\\item[schedul] 215\n",
       "\\item[per] 218\n",
       "\\item[present] 218\n",
       "\\item[administr] 218\n",
       "\\item[design] 219\n",
       "\\item[enrol] 221\n",
       "\\item[end] 221\n",
       "\\item[X100] 225\n",
       "\\item[case] 233\n",
       "\\item[neutropenia] 234\n",
       "\\item[whether] 235\n",
       "\\item[lower] 236\n",
       "\\item[infus] 237\n",
       "\\item[found] 238\n",
       "\\item[nausea] 239\n",
       "\\item[prospect] 239\n",
       "\\item[agent] 240\n",
       "\\item[confid] 241\n",
       "\\item[prognost] 242\n",
       "\\item[radiotherapi] 244\n",
       "\\item[achiev] 245\n",
       "\\item[rang] 248\n",
       "\\item[lymph] 249\n",
       "\\item[X0001] 249\n",
       "\\item[carcinoma] 251\n",
       "\\item[demonstr] 251\n",
       "\\item[patholog] 254\n",
       "\\item[relaps] 254\n",
       "\\item[score] 254\n",
       "\\item[valu] 256\n",
       "\\item[advers] 256\n",
       "\\item[negat] 258\n",
       "\\item[develop] 259\n",
       "\\item[six] 261\n",
       "\\item[failur] 262\n",
       "\\item[randomis] 264\n",
       "\\item[safeti] 265\n",
       "\\item[methotrex] 265\n",
       "\\item[iii] 266\n",
       "\\item[endocrin] 266\n",
       "\\item[indic] 269\n",
       "\\item[suggest] 274\n",
       "\\item[initi] 275\n",
       "\\item[mbc] 276\n",
       "\\item[greater] 279\n",
       "\\item[continu] 281\n",
       "\\item[test] 282\n",
       "\\item[cours] 283\n",
       "\\item[stage] 286\n",
       "\\item[sever] 288\n",
       "\\item[axillari] 292\n",
       "\\item[neoadjuv] 293\n",
       "\\item[partial] 295\n",
       "\\item[investig] 295\n",
       "\\item[number] 296\n",
       "\\item[local] 300\n",
       "\\item[incid] 300\n",
       "\\item[reduct] 301\n",
       "\\item[hazard] 301\n",
       "\\item[premenopaus] 303\n",
       "\\item[prior] 305\n",
       "\\item[standard] 305\n",
       "\\item[without] 306\n",
       "\\item[dfs] 310\n",
       "\\item[mean] 310\n",
       "\\item[occur] 312\n",
       "\\item[her2] 314\n",
       "\\item[serum] 315\n",
       "\\item[tumour] 320\n",
       "\\item[administ] 322\n",
       "\\item[earli] 325\n",
       "\\item[well] 328\n",
       "\\item[drug] 332\n",
       "\\item[outcom] 335\n",
       "\\item[epirubicin] 339\n",
       "\\item[howev] 339\n",
       "\\item[baselin] 340\n",
       "\\item[perform] 342\n",
       "\\item[ratio] 344\n",
       "\\item[durat] 344\n",
       "\\item[interv] 349\n",
       "\\item[decreas] 350\n",
       "\\item[less] 351\n",
       "\\item[relat] 351\n",
       "\\item[determin] 352\n",
       "\\item[metastas] 352\n",
       "\\item[previous] 355\n",
       "\\item[express] 356\n",
       "\\item[report] 357\n",
       "\\item[cell] 359\n",
       "\\item[also] 364\n",
       "\\item[diseasefre] 364\n",
       "\\item[among] 365\n",
       "\\item[four] 369\n",
       "\\item[predict] 369\n",
       "\\item[toler] 373\n",
       "\\item[given] 374\n",
       "\\item[high] 378\n",
       "\\item[statist] 384\n",
       "\\item[background] 397\n",
       "\\item[paclitaxel] 397\n",
       "\\item[total] 397\n",
       "\\item[reduc] 400\n",
       "\\item[object] 400\n",
       "\\item[data] 405\n",
       "\\item[surgeri] 407\n",
       "\\item[event] 409\n",
       "\\item[measur] 411\n",
       "\\item[daili] 412\n",
       "\\item[may] 413\n",
       "\\item[higher] 415\n",
       "\\item[addit] 420\n",
       "\\item[estrogen] 421\n",
       "\\item[first] 421\n",
       "\\item[oral] 422\n",
       "\\item[hormon] 428\n",
       "\\item[age] 429\n",
       "\\item[chang] 431\n",
       "\\item[purpos] 434\n",
       "\\item[assign] 435\n",
       "\\item[similar] 438\n",
       "\\item[recurr] 465\n",
       "\\item[alon] 472\n",
       "\\item[placebo] 475\n",
       "\\item[node] 477\n",
       "\\item[phase] 481\n",
       "\\item[doxorubicin] 486\n",
       "\\item[everi] 487\n",
       "\\item[followup] 494\n",
       "\\item[activ] 509\n",
       "\\item[posit] 511\n",
       "\\item[docetaxel] 514\n",
       "\\item[bone] 514\n",
       "\\item[show] 516\n",
       "\\item[includ] 529\n",
       "\\item[either] 532\n",
       "\\item[status] 538\n",
       "\\item[benefit] 551\n",
       "\\item[factor] 552\n",
       "\\item[advanc] 556\n",
       "\\item[improv] 562\n",
       "\\item[three] 564\n",
       "\\item[one] 570\n",
       "\\item[versus] 570\n",
       "\\item[receptor] 573\n",
       "\\item[grade] 580\n",
       "\\item[cmf] 586\n",
       "\\item[analysi] 587\n",
       "\\item[postmenopaus] 590\n",
       "\\item[efficaci] 591\n",
       "\\item[associ] 604\n",
       "\\item[control] 621\n",
       "\\item[plus] 622\n",
       "\\item[progress] 622\n",
       "\\item[complet] 628\n",
       "\\item[cyclophosphamid] 632\n",
       "\\item[risk] 635\n",
       "\\item[assess] 668\n",
       "\\item[follow] 675\n",
       "\\item[observ] 700\n",
       "\\item[primari] 718\n",
       "\\item[increas] 729\n",
       "\\item[level] 743\n",
       "\\item[metastat] 755\n",
       "\\item[respect] 758\n",
       "\\item[regimen] 807\n",
       "\\item[conclus] 842\n",
       "\\item[time] 881\n",
       "\\item[two] 889\n",
       "\\item[method] 892\n",
       "\\item[treat] 893\n",
       "\\item[combin] 926\n",
       "\\item[evalu] 926\n",
       "\\item[clinic] 944\n",
       "\\item[diseas] 950\n",
       "\\item[cycl] 962\n",
       "\\item[overal] 962\n",
       "\\item[arm] 1038\n",
       "\\item[use] 1053\n",
       "\\item[toxic] 1065\n",
       "\\item[week] 1074\n",
       "\\item[mgm2] 1093\n",
       "\\item[tumor] 1122\n",
       "\\item[dose] 1123\n",
       "\\item[adjuv] 1162\n",
       "\\item[differ] 1176\n",
       "\\item[median] 1180\n",
       "\\item[day] 1245\n",
       "\\item[rate] 1253\n",
       "\\item[year] 1335\n",
       "\\item[effect] 1340\n",
       "\\item[compar] 1359\n",
       "\\item[trial] 1417\n",
       "\\item[women] 1484\n",
       "\\item[result] 1485\n",
       "\\item[random] 1520\n",
       "\\item[therapi] 1564\n",
       "\\item[month] 1575\n",
       "\\item[tamoxifen] 1632\n",
       "\\item[receiv] 1908\n",
       "\\item[surviv] 1927\n",
       "\\item[studi] 1965\n",
       "\\item[signific] 2043\n",
       "\\item[respons] 2051\n",
       "\\item[chemotherapi] 2344\n",
       "\\item[group] 2668\n",
       "\\item[treatment] 2894\n",
       "\\item[cancer] 3726\n",
       "\\item[breast] 3859\n",
       "\\item[patient] 8381\n",
       "\\end{description*}\n"
      ],
      "text/markdown": [
       "regard\n",
       ":   105seven\n",
       ":   108larg\n",
       ":   108avail\n",
       ":   108progesteron\n",
       ":   114trend\n",
       ":   115caus\n",
       ":   115comparison\n",
       ":   116hematolog\n",
       ":   117shown\n",
       ":   117enter\n",
       ":   117characterist\n",
       ":   119regress\n",
       ":   120major\n",
       ":   122defin\n",
       ":   123analyz\n",
       ":   124base\n",
       ":   124eight\n",
       ":   124X005\n",
       ":   124select\n",
       ":   124inform\n",
       ":   124proport\n",
       ":   125prolong\n",
       ":   125type\n",
       ":   126multicent\n",
       ":   126general\n",
       ":   126limit\n",
       ":   127histolog\n",
       ":   127need\n",
       ":   128andor\n",
       ":   128possibl\n",
       ":   130consid\n",
       ":   131main\n",
       ":   131start\n",
       ":   131import\n",
       ":   138second\n",
       ":   138estim\n",
       ":   139prevent\n",
       ":   143particip\n",
       ":   144human\n",
       ":   144obtain\n",
       ":   147detect\n",
       ":   148identifi\n",
       ":   148singl\n",
       ":   149independ\n",
       ":   149distant\n",
       ":   149doubleblind\n",
       ":   149evid\n",
       ":   150receptorposit\n",
       ":   152term\n",
       ":   153frequent\n",
       ":   153multivari\n",
       ":   154stabl\n",
       ":   154due\n",
       ":   154provid\n",
       ":   155potenti\n",
       ":   156secondari\n",
       ":   158remain\n",
       ":   158profil\n",
       ":   158progressionfre\n",
       ":   158superior\n",
       ":   161popul\n",
       ":   162X001\n",
       ":   162appear\n",
       ":   164mastectomi\n",
       ":   165experienc\n",
       ":   167sequenti\n",
       ":   168requir\n",
       ":   168side\n",
       ":   168X500\n",
       ":   169period\n",
       ":   170aromatas\n",
       ":   171new\n",
       ":   171sampl\n",
       ":   172within\n",
       ":   172wherea\n",
       ":   173five\n",
       ":   173vomit\n",
       ":   174pretreat\n",
       ":   175least\n",
       ":   177size\n",
       ":   177find\n",
       ":   177postop\n",
       ":   177analys\n",
       ":   177conduct\n",
       ":   177life\n",
       ":   178confirm\n",
       ":   178involv\n",
       ":   180model\n",
       ":   180firstlin\n",
       ":   182inhibitor\n",
       ":   182accord\n",
       ":   182support\n",
       ":   183site\n",
       ":   183aim\n",
       ":   185better\n",
       ":   186function.\n",
       ":   188marker\n",
       ":   189qualiti\n",
       ":   189examin\n",
       ":   190can\n",
       ":   191common\n",
       ":   191although\n",
       ":   191set\n",
       ":   191subgroup\n",
       ":   192intraven\n",
       ":   192oper\n",
       ":   193longer\n",
       ":   193system\n",
       ":   193hundr\n",
       ":   195elig\n",
       ":   196low\n",
       ":   196tissu\n",
       ":   197nodeposit\n",
       ":   199seen\n",
       ":   199consist\n",
       ":   200respond\n",
       ":   200point\n",
       ":   202correl\n",
       ":   203anthracyclin\n",
       ":   207X5fluorouracil\n",
       ":   208growth\n",
       ":   208endpoint\n",
       ":   213death\n",
       ":   215fluorouracil\n",
       ":   215schedul\n",
       ":   215per\n",
       ":   218present\n",
       ":   218administr\n",
       ":   218design\n",
       ":   219enrol\n",
       ":   221end\n",
       ":   221X100\n",
       ":   225case\n",
       ":   233neutropenia\n",
       ":   234whether\n",
       ":   235lower\n",
       ":   236infus\n",
       ":   237found\n",
       ":   238nausea\n",
       ":   239prospect\n",
       ":   239agent\n",
       ":   240confid\n",
       ":   241prognost\n",
       ":   242radiotherapi\n",
       ":   244achiev\n",
       ":   245rang\n",
       ":   248lymph\n",
       ":   249X0001\n",
       ":   249carcinoma\n",
       ":   251demonstr\n",
       ":   251patholog\n",
       ":   254relaps\n",
       ":   254score\n",
       ":   254valu\n",
       ":   256advers\n",
       ":   256negat\n",
       ":   258develop\n",
       ":   259six\n",
       ":   261failur\n",
       ":   262randomis\n",
       ":   264safeti\n",
       ":   265methotrex\n",
       ":   265iii\n",
       ":   266endocrin\n",
       ":   266indic\n",
       ":   269suggest\n",
       ":   274initi\n",
       ":   275mbc\n",
       ":   276greater\n",
       ":   279continu\n",
       ":   281test\n",
       ":   282cours\n",
       ":   283stage\n",
       ":   286sever\n",
       ":   288axillari\n",
       ":   292neoadjuv\n",
       ":   293partial\n",
       ":   295investig\n",
       ":   295number\n",
       ":   296local\n",
       ":   300incid\n",
       ":   300reduct\n",
       ":   301hazard\n",
       ":   301premenopaus\n",
       ":   303prior\n",
       ":   305standard\n",
       ":   305without\n",
       ":   306dfs\n",
       ":   310mean\n",
       ":   310occur\n",
       ":   312her2\n",
       ":   314serum\n",
       ":   315tumour\n",
       ":   320administ\n",
       ":   322earli\n",
       ":   325well\n",
       ":   328drug\n",
       ":   332outcom\n",
       ":   335epirubicin\n",
       ":   339howev\n",
       ":   339baselin\n",
       ":   340perform\n",
       ":   342ratio\n",
       ":   344durat\n",
       ":   344interv\n",
       ":   349decreas\n",
       ":   350less\n",
       ":   351relat\n",
       ":   351determin\n",
       ":   352metastas\n",
       ":   352previous\n",
       ":   355express\n",
       ":   356report\n",
       ":   357cell\n",
       ":   359also\n",
       ":   364diseasefre\n",
       ":   364among\n",
       ":   365four\n",
       ":   369predict\n",
       ":   369toler\n",
       ":   373given\n",
       ":   374high\n",
       ":   378statist\n",
       ":   384background\n",
       ":   397paclitaxel\n",
       ":   397total\n",
       ":   397reduc\n",
       ":   400object\n",
       ":   400data\n",
       ":   405surgeri\n",
       ":   407event\n",
       ":   409measur\n",
       ":   411daili\n",
       ":   412may\n",
       ":   413higher\n",
       ":   415addit\n",
       ":   420estrogen\n",
       ":   421first\n",
       ":   421oral\n",
       ":   422hormon\n",
       ":   428age\n",
       ":   429chang\n",
       ":   431purpos\n",
       ":   434assign\n",
       ":   435similar\n",
       ":   438recurr\n",
       ":   465alon\n",
       ":   472placebo\n",
       ":   475node\n",
       ":   477phase\n",
       ":   481doxorubicin\n",
       ":   486everi\n",
       ":   487followup\n",
       ":   494activ\n",
       ":   509posit\n",
       ":   511docetaxel\n",
       ":   514bone\n",
       ":   514show\n",
       ":   516includ\n",
       ":   529either\n",
       ":   532status\n",
       ":   538benefit\n",
       ":   551factor\n",
       ":   552advanc\n",
       ":   556improv\n",
       ":   562three\n",
       ":   564one\n",
       ":   570versus\n",
       ":   570receptor\n",
       ":   573grade\n",
       ":   580cmf\n",
       ":   586analysi\n",
       ":   587postmenopaus\n",
       ":   590efficaci\n",
       ":   591associ\n",
       ":   604control\n",
       ":   621plus\n",
       ":   622progress\n",
       ":   622complet\n",
       ":   628cyclophosphamid\n",
       ":   632risk\n",
       ":   635assess\n",
       ":   668follow\n",
       ":   675observ\n",
       ":   700primari\n",
       ":   718increas\n",
       ":   729level\n",
       ":   743metastat\n",
       ":   755respect\n",
       ":   758regimen\n",
       ":   807conclus\n",
       ":   842time\n",
       ":   881two\n",
       ":   889method\n",
       ":   892treat\n",
       ":   893combin\n",
       ":   926evalu\n",
       ":   926clinic\n",
       ":   944diseas\n",
       ":   950cycl\n",
       ":   962overal\n",
       ":   962arm\n",
       ":   1038use\n",
       ":   1053toxic\n",
       ":   1065week\n",
       ":   1074mgm2\n",
       ":   1093tumor\n",
       ":   1122dose\n",
       ":   1123adjuv\n",
       ":   1162differ\n",
       ":   1176median\n",
       ":   1180day\n",
       ":   1245rate\n",
       ":   1253year\n",
       ":   1335effect\n",
       ":   1340compar\n",
       ":   1359trial\n",
       ":   1417women\n",
       ":   1484result\n",
       ":   1485random\n",
       ":   1520therapi\n",
       ":   1564month\n",
       ":   1575tamoxifen\n",
       ":   1632receiv\n",
       ":   1908surviv\n",
       ":   1927studi\n",
       ":   1965signific\n",
       ":   2043respons\n",
       ":   2051chemotherapi\n",
       ":   2344group\n",
       ":   2668treatment\n",
       ":   2894cancer\n",
       ":   3726breast\n",
       ":   3859patient\n",
       ":   8381\n",
       "\n"
      ],
      "text/plain": [
       "         regard           seven            larg           avail     progesteron \n",
       "            105             108             108             108             114 \n",
       "          trend            caus      comparison       hematolog           shown \n",
       "            115             115             116             117             117 \n",
       "          enter    characterist         regress           major           defin \n",
       "            117             119             120             122             123 \n",
       "         analyz            base           eight            X005          select \n",
       "            124             124             124             124             124 \n",
       "         inform         proport         prolong            type       multicent \n",
       "            124             125             125             126             126 \n",
       "        general           limit        histolog            need           andor \n",
       "            126             127             127             128             128 \n",
       "        possibl          consid            main           start          import \n",
       "            130             131             131             131             138 \n",
       "         second           estim         prevent        particip           human \n",
       "            138             139             143             144             144 \n",
       "         obtain          detect        identifi           singl        independ \n",
       "            147             148             148             149             149 \n",
       "        distant     doubleblind            evid   receptorposit            term \n",
       "            149             149             150             152             153 \n",
       "       frequent       multivari           stabl             due          provid \n",
       "            153             154             154             154             155 \n",
       "        potenti       secondari          remain          profil  progressionfre \n",
       "            156             158             158             158             158 \n",
       "       superior           popul            X001          appear      mastectomi \n",
       "            161             162             162             164             165 \n",
       "      experienc        sequenti          requir            side            X500 \n",
       "            167             168             168             168             169 \n",
       "         period        aromatas             new           sampl          within \n",
       "            170             171             171             172             172 \n",
       "         wherea            five           vomit        pretreat           least \n",
       "            173             173             174             175             177 \n",
       "           size            find          postop          analys         conduct \n",
       "            177             177             177             177             177 \n",
       "           life         confirm          involv           model        firstlin \n",
       "            178             178             180             180             182 \n",
       "      inhibitor          accord         support            site             aim \n",
       "            182             182             183             183             185 \n",
       "         better       function.          marker         qualiti          examin \n",
       "            186             188             189             189             190 \n",
       "            can          common        although             set        subgroup \n",
       "            191             191             191             191             192 \n",
       "       intraven            oper          longer          system           hundr \n",
       "            192             193             193             193             195 \n",
       "           elig             low           tissu       nodeposit            seen \n",
       "            196             196             197             199             199 \n",
       "        consist         respond           point          correl    anthracyclin \n",
       "            200             200             202             203             207 \n",
       " X5fluorouracil          growth        endpoint           death    fluorouracil \n",
       "            208             208             213             215             215 \n",
       "        schedul             per         present       administr          design \n",
       "            215             218             218             218             219 \n",
       "          enrol             end            X100            case     neutropenia \n",
       "            221             221             225             233             234 \n",
       "        whether           lower           infus           found          nausea \n",
       "            235             236             237             238             239 \n",
       "       prospect           agent          confid        prognost    radiotherapi \n",
       "            239             240             241             242             244 \n",
       "         achiev            rang           lymph           X0001       carcinoma \n",
       "            245             248             249             249             251 \n",
       "       demonstr        patholog          relaps           score            valu \n",
       "            251             254             254             254             256 \n",
       "         advers           negat         develop             six          failur \n",
       "            256             258             259             261             262 \n",
       "       randomis          safeti       methotrex             iii        endocrin \n",
       "            264             265             265             266             266 \n",
       "          indic         suggest           initi             mbc         greater \n",
       "            269             274             275             276             279 \n",
       "        continu            test           cours           stage           sever \n",
       "            281             282             283             286             288 \n",
       "       axillari        neoadjuv         partial        investig          number \n",
       "            292             293             295             295             296 \n",
       "          local           incid          reduct          hazard     premenopaus \n",
       "            300             300             301             301             303 \n",
       "          prior        standard         without             dfs            mean \n",
       "            305             305             306             310             310 \n",
       "          occur            her2           serum          tumour        administ \n",
       "            312             314             315             320             322 \n",
       "          earli            well            drug          outcom      epirubicin \n",
       "            325             328             332             335             339 \n",
       "          howev         baselin         perform           ratio           durat \n",
       "            339             340             342             344             344 \n",
       "         interv         decreas            less           relat        determin \n",
       "            349             350             351             351             352 \n",
       "       metastas        previous         express          report            cell \n",
       "            352             355             356             357             359 \n",
       "           also      diseasefre           among            four         predict \n",
       "            364             364             365             369             369 \n",
       "          toler           given            high         statist      background \n",
       "            373             374             378             384             397 \n",
       "     paclitaxel           total           reduc          object            data \n",
       "            397             397             400             400             405 \n",
       "        surgeri           event          measur           daili             may \n",
       "            407             409             411             412             413 \n",
       "         higher           addit        estrogen           first            oral \n",
       "            415             420             421             421             422 \n",
       "         hormon             age           chang          purpos          assign \n",
       "            428             429             431             434             435 \n",
       "        similar          recurr            alon         placebo            node \n",
       "            438             465             472             475             477 \n",
       "          phase     doxorubicin           everi        followup           activ \n",
       "            481             486             487             494             509 \n",
       "          posit       docetaxel            bone            show          includ \n",
       "            511             514             514             516             529 \n",
       "         either          status         benefit          factor          advanc \n",
       "            532             538             551             552             556 \n",
       "         improv           three             one          versus        receptor \n",
       "            562             564             570             570             573 \n",
       "          grade             cmf         analysi    postmenopaus        efficaci \n",
       "            580             586             587             590             591 \n",
       "         associ         control            plus        progress         complet \n",
       "            604             621             622             622             628 \n",
       "cyclophosphamid            risk          assess          follow          observ \n",
       "            632             635             668             675             700 \n",
       "        primari         increas           level        metastat         respect \n",
       "            718             729             743             755             758 \n",
       "        regimen         conclus            time             two          method \n",
       "            807             842             881             889             892 \n",
       "          treat          combin           evalu          clinic          diseas \n",
       "            893             926             926             944             950 \n",
       "           cycl          overal             arm             use           toxic \n",
       "            962             962            1038            1053            1065 \n",
       "           week            mgm2           tumor            dose           adjuv \n",
       "           1074            1093            1122            1123            1162 \n",
       "         differ          median             day            rate            year \n",
       "           1176            1180            1245            1253            1335 \n",
       "         effect          compar           trial           women          result \n",
       "           1340            1359            1417            1484            1485 \n",
       "         random         therapi           month       tamoxifen          receiv \n",
       "           1520            1564            1575            1632            1908 \n",
       "         surviv           studi        signific         respons    chemotherapi \n",
       "           1927            1965            2043            2051            2344 \n",
       "          group       treatment          cancer          breast         patient \n",
       "           2668            2894            3726            3859            8381 "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sort(colSums(dtmAbstract))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "colnames(dtmTitle) = paste0(\"T\", colnames(dtmTitle))\n",
    "colnames(dtmAbstract) = paste0(\"A\", colnames(dtmAbstract))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "dtm = cbind(dtmTitle, dtmAbstract)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "dtm$trial = trials$trial"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "'data.frame':\t1860 obs. of  367 variables:\n",
      " $ Tcancer         : num  1 0 1 1 1 1 0 1 1 2 ...\n",
      " $ Ttreatment      : num  1 0 0 0 1 0 0 0 0 1 ...\n",
      " $ Tbreast         : num  0 0 1 1 1 1 0 1 1 1 ...\n",
      " $ Tearli          : num  0 0 1 1 0 0 0 1 0 0 ...\n",
      " $ Tiii            : num  0 0 1 0 0 0 0 0 0 1 ...\n",
      " $ Tphase          : num  0 0 1 1 0 0 0 0 0 1 ...\n",
      " $ Trandom         : num  0 0 1 1 1 0 0 0 0 1 ...\n",
      " $ Ttrial          : num  0 0 1 1 1 0 0 1 1 1 ...\n",
      " $ Tversus         : num  0 0 1 0 0 0 0 1 0 0 ...\n",
      " $ Tcyclophosphamid: num  0 0 0 1 0 0 0 0 0 0 ...\n",
      " $ Tchemotherapi   : num  0 0 0 0 1 1 0 0 0 0 ...\n",
      " $ Tcombin         : num  0 0 0 0 1 0 1 0 0 0 ...\n",
      " $ Teffect         : num  0 0 0 0 1 0 0 1 0 1 ...\n",
      " $ Tmetastat       : num  0 0 0 0 1 0 0 0 0 0 ...\n",
      " $ Tpatient        : num  0 0 0 0 1 0 1 0 1 1 ...\n",
      " $ Trespons        : num  0 0 0 0 0 1 0 0 0 0 ...\n",
      " $ Tadvanc         : num  0 0 0 0 0 0 1 0 0 0 ...\n",
      " $ Tpostmenopaus   : num  0 0 0 0 0 0 0 1 1 0 ...\n",
      " $ Trandomis       : num  0 0 0 0 0 0 0 1 1 0 ...\n",
      " $ Tstudi          : num  0 0 0 0 0 0 0 1 0 0 ...\n",
      " $ Ttamoxifen      : num  0 0 0 0 0 0 0 2 1 0 ...\n",
      " $ Twomen          : num  0 0 0 0 0 0 0 1 0 0 ...\n",
      " $ Tadjuv          : num  0 0 0 0 0 0 0 0 1 0 ...\n",
      " $ Tgroup          : num  0 0 0 0 0 0 0 0 1 1 ...\n",
      " $ Ttherapi        : num  0 0 0 0 0 0 0 0 0 0 ...\n",
      " $ Tcompar         : num  0 0 0 0 0 0 0 0 0 0 ...\n",
      " $ Tdoxorubicin    : num  0 0 0 0 0 0 0 0 0 0 ...\n",
      " $ Tdocetaxel      : num  0 0 0 0 0 0 0 0 0 0 ...\n",
      " $ Tresult         : num  0 0 0 0 0 0 0 0 0 0 ...\n",
      " $ Tplus           : num  0 0 0 0 0 0 0 0 0 0 ...\n",
      " $ Tclinic         : num  0 0 0 0 0 0 0 0 0 0 ...\n",
      " $ AX100           : num  0 1 0 0 0 0 0 0 0 0 ...\n",
      " $ Aactiv          : num  0 2 0 1 0 0 1 0 0 0 ...\n",
      " $ Aassess         : num  0 2 1 2 0 1 0 0 0 3 ...\n",
      " $ Abreast         : num  0 2 3 3 3 4 2 2 2 3 ...\n",
      " $ Acarcinoma      : num  0 5 0 0 0 0 0 0 0 2 ...\n",
      " $ Acase           : num  0 11 0 0 1 0 0 0 0 0 ...\n",
      " $ Acell           : num  0 3 0 0 0 1 0 0 0 0 ...\n",
      " $ Aclinic         : num  0 1 0 1 0 0 0 0 0 0 ...\n",
      " $ Aconsist        : num  0 1 0 0 0 0 0 0 0 0 ...\n",
      " $ Acontrol        : num  0 1 0 0 0 0 0 0 1 0 ...\n",
      " $ Adiffer         : num  0 1 2 1 3 0 0 1 0 1 ...\n",
      " $ Adiseas         : num  0 1 0 1 3 0 0 1 0 0 ...\n",
      " $ Aless           : num  0 4 1 0 0 0 0 0 0 6 ...\n",
      " $ Anegat          : num  0 4 0 0 0 3 0 0 0 0 ...\n",
      " $ Aobserv         : num  0 2 1 0 1 0 0 0 0 0 ...\n",
      " $ Aone            : num  0 1 0 0 0 0 0 0 0 0 ...\n",
      " $ Apatient        : num  0 1 9 5 5 6 8 3 2 5 ...\n",
      " $ Apopul          : num  0 8 0 0 0 0 0 0 0 0 ...\n",
      " $ Aposit          : num  0 2 0 1 0 5 0 0 0 0 ...\n",
      " $ Aseven          : num  0 1 0 0 0 0 0 0 0 0 ...\n",
      " $ Ashow           : num  0 2 0 0 1 0 1 0 0 3 ...\n",
      " $ Astudi          : num  0 1 1 1 0 1 3 2 0 1 ...\n",
      " $ Atest           : num  0 2 1 1 0 0 0 0 0 0 ...\n",
      " $ Atherapi        : num  0 2 0 1 0 0 0 0 0 0 ...\n",
      " $ AX500           : num  0 0 1 0 2 0 0 0 0 0 ...\n",
      " $ Aaddit          : num  0 0 2 0 0 0 0 0 0 0 ...\n",
      " $ Aamong          : num  0 0 2 4 0 0 0 0 1 0 ...\n",
      " $ Aarm            : num  0 0 7 4 2 0 0 1 0 1 ...\n",
      " $ Aassign         : num  0 0 2 1 0 0 0 1 1 1 ...\n",
      " $ Aassoci         : num  0 0 1 3 0 2 0 1 2 0 ...\n",
      " $ Abackground     : num  0 0 1 1 1 0 0 1 1 0 ...\n",
      " $ Abetter         : num  0 0 1 0 1 1 0 0 0 0 ...\n",
      " $ Acancer         : num  0 0 2 3 3 3 2 2 3 0 ...\n",
      " $ Achang          : num  0 0 1 0 0 0 0 0 0 0 ...\n",
      " $ Achemotherapi   : num  0 0 1 2 3 5 2 0 1 0 ...\n",
      " $ Acompar         : num  0 0 1 2 0 0 0 1 1 1 ...\n",
      " $ Acomplet        : num  0 0 3 0 1 1 1 2 0 0 ...\n",
      " $ Aconclus        : num  0 0 1 0 1 0 0 0 0 0 ...\n",
      " $ Aconfid         : num  0 0 1 1 0 0 0 0 0 0 ...\n",
      " $ Acontinu        : num  0 0 2 0 1 0 0 2 0 0 ...\n",
      " $ Acycl           : num  0 0 6 0 2 0 1 0 0 0 ...\n",
      " $ Acyclophosphamid: num  0 0 1 1 1 1 3 0 0 0 ...\n",
      " $ Aday            : num  0 0 1 0 0 0 3 0 0 0 ...\n",
      " $ Adecreas        : num  0 0 1 0 0 0 0 0 1 0 ...\n",
      " $ Adefin          : num  0 0 2 0 0 0 0 0 0 0 ...\n",
      " $ Ademonstr       : num  0 0 1 0 0 0 0 0 0 0 ...\n",
      " $ Adocetaxel      : num  0 0 1 0 0 0 3 0 0 0 ...\n",
      " $ Adoxorubicin    : num  0 0 1 0 0 1 0 0 0 0 ...\n",
      " $ Aeffect         : num  0 0 2 0 0 1 0 2 0 1 ...\n",
      " $ Aefficaci       : num  0 0 1 0 0 0 0 0 0 0 ...\n",
      " $ Aenrol          : num  0 0 1 0 0 0 1 0 0 1 ...\n",
      " $ Afour           : num  0 0 4 0 0 0 0 0 0 0 ...\n",
      " $ Ahematolog      : num  0 0 1 0 0 0 0 0 0 0 ...\n",
      " $ Ainiti          : num  0 0 3 0 0 0 0 1 0 0 ...\n",
      " $ Ainterv         : num  0 0 1 1 0 0 0 0 0 0 ...\n",
      " $ Aleast          : num  0 0 2 0 0 0 0 0 0 0 ...\n",
      " $ Alymph          : num  0 0 1 4 0 3 0 0 1 0 ...\n",
      " $ Amethod         : num  0 0 1 0 1 0 0 1 1 0 ...\n",
      " $ Amgm2           : num  0 0 5 0 4 0 9 0 0 0 ...\n",
      " $ Aneoadjuv       : num  0 0 2 0 0 0 0 0 0 0 ...\n",
      " $ Anode           : num  0 0 1 3 0 0 0 0 1 0 ...\n",
      " $ Anumber         : num  0 0 1 1 0 2 1 0 0 0 ...\n",
      " $ Aoutcom         : num  0 0 2 0 0 0 0 0 0 2 ...\n",
      " $ Apatholog       : num  0 0 3 0 0 1 0 0 0 0 ...\n",
      " $ Aper            : num  0 0 1 0 0 0 0 0 0 0 ...\n",
      " $ Aprevious       : num  0 0 1 0 1 0 2 0 0 0 ...\n",
      " $ Arandom         : num  0 0 2 1 1 0 0 1 1 2 ...\n",
      " $ Arate           : num  0 0 1 1 2 0 1 0 1 0 ...\n",
      "  [list output truncated]\n"
     ]
    }
   ],
   "source": [
    "str(dtm)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [],
   "source": [
    "library(caTools)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "set.seed(144)\n",
    "spl = sample.split(dtm$trial , 0.7)\n",
    "train = subset(dtm, spl == TRUE)\n",
    "test = subset(dtm, spl == FALSE)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\n",
       "  0   1 \n",
       "730 572 "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "table(train$trial)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\n",
       "  0   1 \n",
       "313 245 "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "table(test$trial)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "0.560931899641577"
      ],
      "text/latex": [
       "0.560931899641577"
      ],
      "text/markdown": [
       "0.560931899641577"
      ],
      "text/plain": [
       "[1] 0.5609319"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "accBaseline = 313/nrow(test)\n",
    "accBaseline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "library(rpart)\n",
    "library(rpart.plot)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA0gAAANICAMAAADKOT/pAAADAFBMVEUAAAABAQECAgIDAwME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\ngoFIMAji3SVc8QPKfwAAAABJRU5ErkJggg==",
      "text/plain": [
       "plot without title"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "trialCART = rpart(trial ~. , data = train, method = \"class\")\n",
    "prp(trialCART)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "0.871886120996441"
      ],
      "text/latex": [
       "0.871886120996441"
      ],
      "text/markdown": [
       "0.871886120996441"
      ],
      "text/plain": [
       "[1] 0.8718861"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "predTrain = predict(trialCART)\n",
    "max(predTrain[,2])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "   \n",
       "    FALSE TRUE\n",
       "  0   631   99\n",
       "  1   131  441"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "table(train$trial,predTrain[,2] >= 0.5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "0.823348694316436"
      ],
      "text/latex": [
       "0.823348694316436"
      ],
      "text/markdown": [
       "0.823348694316436"
      ],
      "text/plain": [
       "[1] 0.8233487"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "accTrain = (631 + 441)/nrow(train)\n",
    "accTrain"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "0.770979020979021"
      ],
      "text/latex": [
       "0.770979020979021"
      ],
      "text/markdown": [
       "0.770979020979021"
      ],
      "text/plain": [
       "[1] 0.770979"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sensitivity = (441)/(441 + 131)\n",
    "sensitivity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "0.864383561643836"
      ],
      "text/latex": [
       "0.864383561643836"
      ],
      "text/markdown": [
       "0.864383561643836"
      ],
      "text/plain": [
       "[1] 0.8643836"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "specifity = (631)/(631 + 99)\n",
    "specifity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "   \n",
       "    FALSE TRUE\n",
       "  0   261   52\n",
       "  1    83  162"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "predTest = predict(trialCART, newdata = test)[,2]\n",
    "table(test$trial,predTest >= 0.5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "0.758064516129032"
      ],
      "text/latex": [
       "0.758064516129032"
      ],
      "text/markdown": [
       "0.758064516129032"
      ],
      "text/plain": [
       "[1] 0.7580645"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "accTest = (261 + 162)/nrow(test)\n",
    "accTest"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {},
   "outputs": [],
   "source": [
    "library(ROCR)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "0.837106344135098"
      ],
      "text/latex": [
       "0.837106344135098"
      ],
      "text/markdown": [
       "0.837106344135098"
      ],
      "text/plain": [
       "[1] 0.8371063"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ROCRpredTest = prediction(predTest, test$trial)\n",
    "auc = as.numeric(performance(ROCRpredTest, \"auc\")@y.values)\n",
    "auc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "   \n",
       "    FALSE TRUE\n",
       "  0   215   98\n",
       "  1    29  216"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "predTest = predict(trialCART, newdata = test)[,2]\n",
    "table(test$trial,predTest >= 0.2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "   \n",
       "    FALSE TRUE\n",
       "  0   301   12\n",
       "  1   152   93"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "predTest = predict(trialCART, newdata = test)[,2]\n",
    "table(test$trial,predTest >= 0.8)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "R",
   "language": "R",
   "name": "ir"
  },
  "language_info": {
   "codemirror_mode": "r",
   "file_extension": ".r",
   "mimetype": "text/x-r-source",
   "name": "R",
   "pygments_lexer": "r",
   "version": "3.5.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
